ES2095258T3 - Nuevo virus de la enfermedad de la bolsa infecciosa. - Google Patents
Nuevo virus de la enfermedad de la bolsa infecciosa.Info
- Publication number
- ES2095258T3 ES2095258T3 ES90915645T ES90915645T ES2095258T3 ES 2095258 T3 ES2095258 T3 ES 2095258T3 ES 90915645 T ES90915645 T ES 90915645T ES 90915645 T ES90915645 T ES 90915645T ES 2095258 T3 ES2095258 T3 ES 2095258T3
- Authority
- ES
- Spain
- Prior art keywords
- infectious
- virus
- new viruses
- disease
- bag disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
- A21D2/364—Nuts, e.g. cocoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
SE IDENTIFICA EN FORMA ESENCIALMENTE PURA, UN NUEVO VIRUS NO NEUTRALIZADO O ENLAZADO MEDIANTE ANTICUERPOS MONOCLONALES QUE NEUTRALIZAN EN GRUPO TODAS LAS VACUNAS IBDV ACTUALES, Y CAPAZ DE INDUCIR LA ENFERMEDAD BURSAL INFECCIOSA EN LAS AVES. SE DESCRIBE, UN EQUIPO DE EXAMEN, Y UN ENSAYO PARA DETECTAR EL VIRUS, JUNTO CON LA VACUNA QUE INCORPORA EL VIRUS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42375789A | 1989-10-18 | 1989-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2095258T3 true ES2095258T3 (es) | 1997-02-16 |
Family
ID=23680061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90915645T Expired - Lifetime ES2095258T3 (es) | 1989-10-18 | 1990-09-27 | Nuevo virus de la enfermedad de la bolsa infecciosa. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0496787B1 (es) |
JP (1) | JPH05504049A (es) |
AT (1) | ATE145236T1 (es) |
AU (1) | AU6605190A (es) |
CA (1) | CA2067397A1 (es) |
DE (1) | DE69029145T2 (es) |
ES (1) | ES2095258T3 (es) |
NZ (1) | NZ235474A (es) |
WO (1) | WO1991005569A1 (es) |
ZA (1) | ZA908260B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL103939A (en) * | 1992-12-01 | 1996-09-12 | Abic Ltd | An anti-DBI vaccine in birds containing attenuated live DBI virus |
US5871744A (en) * | 1996-09-05 | 1999-02-16 | University Of Maryland-Biotechnology Inst. | Method for generating birnavirus from synthetic RNA transcripts |
EP0861665A1 (en) | 1997-02-03 | 1998-09-02 | Dimminaco Ag/Sa/Ltd. | Infectious bursitis vaccine |
US6231868B1 (en) | 1997-09-30 | 2001-05-15 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
ES2608599T3 (es) | 2004-03-12 | 2017-04-12 | Zoetis Services Llc | Aislados y vacunas antigénicos del virus de la enfermedad de bursitis Infecciosa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530831A (en) * | 1982-11-02 | 1985-07-23 | Akzo N.V. | Infectious Bursal Disease vaccine |
US4824668A (en) * | 1987-03-09 | 1989-04-25 | Sterwin Laboratories Inc. | Attenuated infectious bursal disease virus strain and vaccine therefrom |
US4956452A (en) * | 1987-06-14 | 1990-09-11 | The University Of Maryland | Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus |
US5064646A (en) * | 1988-08-02 | 1991-11-12 | The University Of Maryland | Novel infectious bursal disease virus |
-
1990
- 1990-09-26 NZ NZ23547490A patent/NZ235474A/xx unknown
- 1990-09-27 AT AT90915645T patent/ATE145236T1/de not_active IP Right Cessation
- 1990-09-27 AU AU66051/90A patent/AU6605190A/en not_active Abandoned
- 1990-09-27 JP JP2514513A patent/JPH05504049A/ja active Pending
- 1990-09-27 EP EP19900915645 patent/EP0496787B1/en not_active Expired - Lifetime
- 1990-09-27 ES ES90915645T patent/ES2095258T3/es not_active Expired - Lifetime
- 1990-09-27 CA CA 2067397 patent/CA2067397A1/en not_active Abandoned
- 1990-09-27 DE DE69029145T patent/DE69029145T2/de not_active Expired - Fee Related
- 1990-09-27 WO PCT/US1990/005428 patent/WO1991005569A1/en active IP Right Grant
- 1990-10-16 ZA ZA908260A patent/ZA908260B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ235474A (en) | 1992-12-23 |
DE69029145T2 (de) | 1997-05-07 |
ZA908260B (en) | 1991-08-28 |
JPH05504049A (ja) | 1993-07-01 |
AU6605190A (en) | 1991-05-16 |
EP0496787A4 (en) | 1993-04-28 |
EP0496787A1 (en) | 1992-08-05 |
DE69029145D1 (de) | 1996-12-19 |
ATE145236T1 (de) | 1996-11-15 |
CA2067397A1 (en) | 1991-04-19 |
EP0496787B1 (en) | 1996-11-13 |
WO1991005569A1 (en) | 1991-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI910497A0 (fi) | Nytt virus vid infektioes bursalsjukdom. | |
ATE131067T1 (de) | Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose. | |
ATE60799T1 (de) | Virus-impfstoff. | |
BR9306984A (pt) | Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo | |
FI870447A (fi) | Htlv-iii-hoeljepeptider. | |
ZA872166B (en) | Synthetic htlv-iii peptides,compositions and uses thereof | |
DK0755684T3 (da) | Vaccinekonjugat | |
ES2095258T3 (es) | Nuevo virus de la enfermedad de la bolsa infecciosa. | |
ES2056075T3 (es) | Anticuerpos monoclonales para regiones especificas antigenicas del virus de inmunodeficiencia humana y procedimientos para su uso. | |
DE69333730D1 (de) | Impfstoff, der acemannan als adjuvans enthält | |
KR920007636A (ko) | 신규의 백신체 | |
Bouges-Bocquet et al. | In vitro genetic constructions devised to express given antigenic determinants at the surface of gram-negative bacteria. | |
FI972658A (fi) | Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan | |
Erdei et al. | Use of the ELISA-test for the serological screening for Aujeszky's virus infection in large-scale swine stocks. | |
Egorenkova et al. | Use of enzyme-immunoassay with Staphylococcus protein A/peroxidase conjugate in serodiagnosis of influenza. | |
UWATOKO et al. | Hemagglutination with crane herpesvirus | |
Njayou et al. | Preparation and evaluation of an IgG-Lucifer Yellow carbohydrazide conjugate for the detection of measles antigen | |
SE8701294L (sv) | Hiv-peptid | |
ES2055687T3 (es) | Vacuna de virus. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 496787 Country of ref document: ES |